T he last decade has seen a burgeoning interest not only in research in first-episode psychosis (FEP), its treatment, and early detection but also in the establishment of several early intervention (EI) services. While the enthusiasm for EI is inherently appealing, it has its detractors. Whether the benefits of a specialized EI approach to treatment of FEP are worth the costs it may incur has generated some heated debate. While we do not have all the answers yet, I will argue that this new development in service delivery is based on good evidence and likely to be cost-beneficial in the long run.
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To shed more light, rather than simply generate more heat, it is important to examine several key questions related to EI and its benefits. What is EI? Is it effective? Is it worth the cost and should EI be incorporated into mental health policy in Canada? Should EI include services for patients in the so-called prodromal stage of psychosis?
There are several sources of ambiguity in the term EI that go beyond semantics. In the treatment of an FEP, 2 components of EI need to be clearly defined, one that relates to a phase-specific and specialized approach to treatment and the other that addresses issues of reducing delay through early case identification. An additional and more contentious issue relates to treatment of prodromal state.
The 2-pronged question most often raised is: Why establish a new and specialized service for this patient population, and why not treat them in the same services as those with more established and chronic illness? The argument for a specialized approach to treatment in the early phase of psychosis goes something like this: in routine care, clinical response to treatment of FEP is generally very good, with relatively high rates of reduction in level of psychotic symptoms and more modest reduction of negative symptoms, often, however, followed by relatively high rates of relapse within the first 2 to 5 years. 1 Trajectories of long-term outcome are often defined relatively early in the course of illness. 2 More intensive efforts at treatment during the early phase may improve outcome, at least for a substantial proportion of patients. In routine psychiatric services, highly specialized and intensive care is usually not introduced until considerably later in the course of illness, after considerable decline in functioning develops. Interventions at this late stage are unlikely to result in any substantial clinical or functional gains. The existent system is generally not equipped to deal with special needs of the young patients (and their family) with a new onset of psychosis. For example, such needs are associated with a significantly younger age, specific developmental stage, nature of psychopathology leading to ambiguity in diagnosis, naïveté to the mental health system, and high rate of recreational substance use. Such special characteristics of FEP patients render them unlikely to engage or stay in and be adherent to treatment.
In general, most EI services provide a modified version of an assertive case management program along with rational pharmacotherapy and specific psychological interventions such as cognitive-behavioural therapy (CBT) and family intervention. Two recent randomized controlled studies and numerous, mostly uncontrolled and quasi-experimental, studies have shown that specialized EI services provide superior effectiveness on measures of psychopathology, rates of remission and relapse, adherence to and retention in treatment, greater family involvement in treatment, and better community adjustment. 3, 4 A recent meta-analysis has confirmed that an enriched intervention provided to patients with FEP is likely to produce significantly better clinical and functional outcome, compared with routine care. 5 Such encouraging results should provoke us to ask more specific questions to further improve the effectiveness of EI and not stop this encouraging development. These questions include:
What patient characteristics require a specialized approach? Are the benefits of EI, shown during the first 2 years, sustained over a longer term and, if not, as seems to be the case, how long do patients require to stay in specialized EI services? Do EI services have a higher penetration rate than standard care? Do EI services address specific problems associated with psychotic disorders such as suicidal behaviour, violence, and unemployment? And are such services cost-effective, including indirect costs, in the long term?
The other component of an EI approach is the reduction of delay in treatment based largely on the frequently replicated association between longer duration of untreated psychosis (DUP) and poor clinical outcome. Attempts at reducing DUP have so far had mixed results, 6, 7 and few studies have examined if reducing DUP can result in improving outcome above and beyond what can be achieved through a specialized treatment approach. One recent report 8 suggests that such reduction in delay may translate into improved outcome, at least in the short term. However, providing prompt access and active case finding to reduce prolonged delays can not only reduce patient and family suffering associated with prolonged psychosis but also likely reduce suicidal behaviour. 9 A substantial proportion of patients endure delays of longer than 1 year. Further research is required to evaluate the most costeffective methods to reduce such long delays.
Are Costs Associated With EI Services Unjustified?
While determining costs of direct care may be feasible, it is significantly more complex to estimate indirect costs such as those associated with loss or gain through employment and (or) schooling, impact on families, and behaviours often associated with continued and untreated psychosis (suicidal and aggressive, victimization, and stigma). Relatively few studies have examined even direct costs associated with EI services, compared with routine care. In an earlier study, Mihalopoulos et al 10 reported cost savings associated with reduced hospitalization that were balanced by higher staffing costs of providing EI services. More recently, in an extension of this study, substantial cost savings associated with initial treatment in an EI service have been reported in an 8-year period. A Canadian study 11 has also reported that following introduction of a new EI service in a defined catchment area, modest cost savings were achieved over a 2-year period following first admission for treatment of FEP 12 through significant reduction in the use of regular hospital beds and use of psychiatric emergency services. No doubt, the new service incurred additional costs associated with staffing and infrastructure that were derived from reorganization of services without any new funds allocated to the system. Such shifts in policy and resource allocation may be necessary to introduce new developments in service, if such services provide benefit to patients. It is unlikely that EI services will result in significantly lower direct costs than those associated with routine care of FEP patients. However, EI service development may be largely achievable through a reallocation of resources in the long term, with some additional transitional investment. The current evidence regarding costs associated with EI services are based on studies not adequately designed or powered to answer such questions definitively. More rigorous designs are needed to address this issue.
Is EI Justified in the Prodromal Phase of Illness?
Interventions during the prepsychotic, putatively prodromal, phase of psychotic disorders have been attracting significant attention in recent years. Currently accepted criteria for identifying people at ultra-high risk (UHR) for psychosis confer a 30% to 40%, 1-year risk of conversion to psychosis, although more recent studies have reported lower conversion rates. Results from pharmacological 13 and (or) psychological 14 treatment studies are encouraging but far from conclusive. Our knowledge still lacks an acceptable estimate of riskbenefit ratio considering relatively noxious side effects of antipsychotic drugs, costs of training and providing therapies such as CBT, and possible stigma associated with treatment of people with false-positive results. Before interventions during the putative prodromal phase are accepted as evidence-based practice, further research is needed to show greater benefits and minimal risks of such preventive interventions beyond what can be achieved through EI services provided promptly to people with a diagnosable FEP. It is also unclear whether the prodromal interventions target people in a prepsychotic state or simply treat those with milder level of psychotic symptoms. Many of the UHR people suffer from various impairments, and may benefit from interventions directly addressing those specific problems without specific interventions for psychosis. A network of EI services incorporating such services for people regarded as UHR for psychosis may be worthy of further examination.
In conclusion, there is ample evidence to support specialized EI services for treatment of a diagnosable FEP. Such services should be structured to include a continuum of inpatient and community components, be sustainable for at least 2 years, and provide prompt access through a flexible and open system, including active case finding through direct links with a wide range of potential sources of referral within the health and education services. Based on the available evidence, mental health policy would be justified in promoting initiation of treatment of FEP, sustained over at least the first 2 years, within specialized EI services. This would indeed improve retention of patients in treatment than is currently possible in routine care. While there is some suggestive evidence that such intervention may need to be sustained beyond the first 2 years, definite evidence to support longer duration of such services is eagerly awaited. It also remains to be demonstrated whether longer duration of such treatment is required for all patients treated for FEP or for only those with special characteristics. Further research is needed to modify treatment approaches for patients who are difficult to engage at first contact, methods to reduce involuntary admission to hospital, and address the diverse needs of small urban and rural areas, different ethnic groups, and Aboriginal people. Mental health policy will need to be responsive to new research findings regarding developments in EI service research. Interventions during the prepsychotic phase must await further, more sophisticated, research support before being promoted as optimum practice. Establishment of carefully monitored EI services is a major step forward in improving outcome in such complex disorders and a rare ray of optimism in a field generally filled with doom and gloom. Stopping this enthusiastic approach to treatment of young people with psychotic disorders on the basis that we do not have all the answers yet would be like throwing the baby out with the bathwater.
Ashok Malla

Specialist EI Teams Are a Waste of Clinical Resources
We're busy doing nothing, working the whole day through Trying to find lots of things not to do.
-Bing Crosby, A Connecticut Yankee in King
Arthur's Court, Paramount 1949 A few years ago, a conference entitled "Sooner or Later" was held in Edinburgh to consider how best to assist people who newly develop a psychotic illness. Delegates included Scotland's deputy health minister as well as patients, their relatives, journalists, and clinicians. During the workshops, a young but careworn-looking woman voiced dismay that a pilot EI service in north Glasgow had not existed when her son first showed signs of becoming unwell. If it had, she would have sold her house and moved to that area for the critical period of his illness.
She was convinced by claims from an international group of psychiatrists and psychologists that it may be possible to prevent many cases of schizophrenia and related illnesses by identifying and specifically treating patients during a prodromal phase. 1 The epidemiologic, clinical, and ethical errors in their approach have been clearly explained in the scientific literature 2 ; however, the false hopes that they raise are becoming increasingly influential. Controversy surrounding primary prevention has diverted attention from EI specialists' work with full-blown psychotic illness. I will suggest here that their theories and methods are leading to inefficient, naive and, in some respects, even dangerous clinical practices.
An Arbitrary Critical Period for Care
Nobody could deny that symptoms and behaviour during initial stages of serious mental disorders can have far-reaching adverse effects on patients' education, employment, and relationships. Also, it is possible that psychosis may have a direct effect on brain function that makes subsequent illness more likely and more severe. 3 Prompt and vigorous treatment is therefore essential. However, for people in the EI movement the first few years have somehow become the only critical period in the management of schizophrenia, manic depression, and related conditions. 4 Presumably because of a lack of prolonged clinical experience with patients, they fail to acknowledge the profound deteriorations that can occur throughout patients' lives when, for example, medication is reduced, or a job is lost, or a spouse cannot cope, or an elderly parent dies. Resources must be available to treat (or prevent where possible) all of these critical periods as and when they occur.
Is Treating Patients With First-Episode Psychosis Cost-Effective?
The Canadian Journal of Psychiatry, Vol 55, No 1, January 2010 W When faced with a high workload, some teams have reduced their clinical input to as little as 18 months. 1 Of course, this means that ordinary clinicians have to spread themselves even more thinly to provide continuing care to these high-priority patients.
Exclusion Criteria
Because of an emphasis on youth-friendly treatment, referrals of people who become ill after they are aged about 30 years are not accepted. This excludes a substantial number of FEP patients-especially females. Lists of other exclusion criteria vary but can contain the following: affective psychoses, brain injury, drug-or alcohol-induced psychosis, and personality disorder. 5 Many of the EI specialists do not accept anybody who has previously been prescribed antipsychotic medication. 6 There can be no medical justification for picking and choosing patients in this way and it is difficult to avoid the conclusion that some EI teams are, in fact, research projects dressed up as clinical services. Whatever the reason, it is for health service managers to get value from ring-fenced public resources and put an end to such inefficient and inequitable practices.
Clinical and Social Outcomes
A recent Cochrane report 7 concluded that there is insufficient evidence from randomized controlled trials to support the introduction of subspecialist teams for FEP. This systematic review was necessarily constrained by the narrow methodology of the Cochrane collaboration. The overall results of several trials in this area still require careful examination by policy-makers and clinicians.
The OPUS study 8 in Denmark, involving 547 patients with a first episode of schizophrenia or a related disorder, compared integrated multidisciplinary care using an assertive outreach model with treatment as usual. After 2 years, there were modest but statistically and clinically significant differences in positive and negative symptoms in favour of the integrated treatment. This group also had slightly less frequent comorbid substance misuse and better adherence and satisfaction with their treatment program.
In the Lambeth Early Onset (LEO) study, 9, 10 144 patients from inner-city London in their first or second psychotic episode were randomized to an EI service or to the sector community mental health teams. The headline findings after 18 months were that a third of the EI group had any readmission, compared with one-half of those who received standard care; 14%, compared with 32%, were no longer in regular contact with their key worker; 30%, compared with 48%, had experienced at least one relapse. Medication adherence was very poor in both groups-79%, compared with 95%, discontinued medicine against medical advice at least once during the study. Satisfaction with treatment, quality-of-life ratings, and certain aspects of social and occupational functioning were better in people who received subspecialist care. At the end of the study, there were still a lot of very unwell patients in both groups, with similar high levels of positive and negative symptoms, and continuing lack of insight.
The OPUS and LEO studies have been used to support the widespread introduction of EI teams. However, these experimental comparisons cannot be used in isolation when deciding on health policy. For example, health service managers and psychiatrists in Denmark should be asking themselves how treatment as usual for schizophrenia in this day and age could consist of office-based care delivered by a doctor and nurse. Standard care in the LEO trial is not properly described in the published papers but the word on the street throughout United Kingdom psychiatry is that inner-city community teams have become demoralized largely owing to poaching of their staff by new specialized services with highly protected caseloads. The clinical methods of OPUS (continuity of care from a key worker, home visits as required, assertive outreach, social skills training, and psychoeducational family treatment) and the LEO team (careful use of antipsychotic medicines, CBT, family counselling, and vocational strategies) are, or should be, standard psychiatric interventions. They may be indicated at any stage of a major mental illness and ready availability must not be confined to the first few years after onset.
This point has been emphasized by Grawe et al 11 whose randomized trial compared integrated care over 2 years with largely clinic-based treatment in 50 patients with schizophrenia of less than 2 years duration. Once again, the integrated model showed some statistically and clinically significant advantages but, for most patients, "two years of intensive treatment was insufficient and further continued intensive efforts are necessary to minimise clinical and social morbidity." 11, p 334 These authors question whether specialized teams would be superior to generic services that are adequately staffed and trained. This echoes the views of Linszen et al 12 who have considered the ethical implications of providing care during the initial episode that is of higher quality than the care that is available to patients in later stages of psychotic illness. During a 15-month program for a first episode of schizophrenia, the relapse rate was reasonably low at around 15%. Patients were then discharged to other agencies and, during the ensuing 5 years, more than one-half developed chronic positive symptoms. They concluded that "it remains questionable whether early intervention programs in first episode patients with a short duration of untreated psychosis can offer the prospect of altering the course of schizophrenia without a sustained treatment program." 12, p 60
Hindering Continuity of Patient Care
This brings us to the most serious flaw in the approach of EI specialists. They have made continuity of care a specific marker of the quality of psychiatric treatment. However, data collection in their outcome studies tends to stop before they transfer their patients-no matter how unwell-to generalist clinicians. 4, 8, 10, 13 If any lesson has been learned from several decades of community care failures and tragedies it is that the time around transfer to a new clinical team is a truly critical period for those with insight-impairing mental disorders. 14 Many of these patients will relapse and hard-pressed general practitioners and ordinary inpatient and community psychiatric teams will, as always, be left to pick up the pieces.
Conclusions
The result of experimental and observational research in the field of FEP are clear-and totally unsurprising: properly funded integrated mental health care is superior to treatment delivered by office-based practitioners or overloaded generic community mental health teams. Many EI specialists have managed to obtain the resources to provide integrated care to selected patients for their arbitrary critical period of a few years. However, they have done so by misleading policymakers and, unforgivably, patients and relatives with exaggerated claims about their abilities to prevent and attenuate major mental disorders. They should get out of the way of ordinary clinicians who are prepared to tackle the real challenges of managing first and subsequent episodes of psychosis-as soon as, and for as long as, their patients require assistance. D r Pelosi argues against a specialized EI approach to treatment of an FEP based almost entirely on fiat, opinions, and conjectures despite acknowledging the evidence to support a specialized approach. Modest that evidence may be, but significant it definitely is. The example of a "careworn-looking woman" provided by the author demonstrates a reluctance to believe the distress associated with the well-documented, tortuous pathways to care encountered by the patients and (or) their families while seeking help for an FEP. Delays encountered within the system even after the first contact for care is made by the patient and (or) their family are now well documented. Earlier timing of intervention is likely to be beneficial, not so much in improving clinical outcome but more to reduce the suffering associated with continuing symptoms of psychosis. Such earlier access can be achieved by relatively simple systemic changes such as removing all referral barriers and making initial assessment flexible. Elaborate case-detection interventions need not be applied beyond research settings where their effectiveness has been shown to be mixed and complex. I know of no evidence to support delaying treatment as often happens currently in routine care in most jurisdictions.
In addition to the 2 controlled studies quoted in Dr Pelosi's argument, a recent meta-analysis using data from uncontrolled and controlled studies has confirmed the superiority of enriched interventions, compared with routine care. The "critical period" is not a figment of imagination, as suggested by Dr Pelosi's argument, but a hypothesis supported by data from long-term outcome studies showing that trajectories of long-term outcome are established within the first 2 years of treatment. Dr Pelosi also continues to ignore the distinction between applying an intensive specialized approach to treatment following onset of syndromal level of a psychotic disorder and experimental interventions applied recently during a putative prodromal period before onset of threshold level of psychotic symptoms. I had already made this distinction clear, as well as a warning against the relatively premature advocacy of antipsychotic medication during the prodromal phase. Contrary to Dr Pelosi's contention, no one, to my knowledge, has suggested that primary prevention is possible in the absence of definitive knowledge about what causes Is Treating Patients With First-Episode Psychosis Cost-Effective?
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Finally, Dr Pelosi bemoans that resources are misused through specialized treatment teams and thus are not available for later stages of the illness. If that is happening in any rearrangement of service organization it is clearly wrong. A high quality of service needs to be maintained at each stage of the illness and evidence clearly suggests that specialized EI approach is at least cost-neutral. As suggested in my original argument, we need to continue an empirical examination of several issues related to specialized EI approach, including the benefit not sustained after specialized EI service is stopped at 2 years. Controlled studies are required to examine the question whether extension of specialized EI to 5 years is likely to produce longer-lasting benefits and what type of patients may require less intensive treatment during the first few years.
Ashok Malla
Patients With Psychotic Illnesses
Require Sustained High-Quality Care D r Malla has provided a measured and thoughtful account of some possible benefits of specialized services for prodromal and FEP and I fully support his calls for more research into the management of these stages of severe mental disorders. He must be embarrassed by the wildly exaggerated claims of others in the EI movement.
One of the most puzzling features of these specialists is the way in which they distort the work and the aspirations of general psychiatrists and their multidisciplinary colleagues. Even Dr Malla makes this mistake. He maintains that routine services only provide intensive care plans once patients become chronically ill. This is simply not true. Generic teams give high priority to patients in the early stages of illness and obtain great satisfaction from this part of their duties. As Dr Malla points out: clinical response to treatment of FEP is generally very good, with relatively high rates of reduction in level of psychotic symptoms and more modest reduction of negative symptoms This phase of treatment is particularly satisfying when it leads to good working relationships with patients and families over the ensuing years-and often decades.
Dr Malla considers the establishment of EI services to be "a rare ray of optimism in a field generally filled with doom and gloom." Is this really the case in Canada? In the United Kingdom, general psychiatrists are certainly full of complaints about mental health services but much of this arises from the knowledge that, given the resources, they could do more to benefit their patients. How did Dr Malla come to the conclusion that specialized interventions in late stages of schizophrenia and related conditions "are unlikely to result in any substantial clinical or functional gains"? For many patients, proper care at these stages makes the difference between existing in a state of quiet squalor and a dignified and enjoyable life. In a small number of important patients, sustained input from a multidisciplinary team prevents potentially violent chaos in thinking and behaviour. Some of the greatest gains in health and social well-being occur when patients with relapsing and remitting illnesses who have been inappropriately discharged from specialist care are re-engaged in treatment. I find it incomprehensible that EI specialists emphasize the importance of prevention in psychiatry and yet they are prepared to discharge patients who are known to be at high risk of relapsing into an insight-impairing illness.
Dr Malla is correct that enthusiasm for EI is inherently appealing. This is what makes the relentless public relations campaign of its more uncritical proponents so worrying. It is the duty of people who have chosen to work in the complicated and demanding field of psychiatry to ask difficult epidemiologic and clinical questions about appealing notions. I can only hope that these and other questions will be raised by patients and their representatives and that they can halt the diversion of resources to clinicians who take naive, short-term approaches to the prevention and treatment of serious mental disorders.
Anthony J Pelosi
